Paul Kim
Board Member
Exagen Inc. (XGN)Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Paul Kim
Paul Kim is recorded as Board Member at Exagen Inc. (XGN). Exagen Inc. reported in an 8-K filed July 24, 2023 that Paul Kim was appointed Class II director, effective July 24, 2023.
“On July 24, 2023, upon recommendation of the Nominating and Corporate Governance Committee of the Board of Directors (the “Board”) of Exagen Inc. (the “Company”), and pursuant to the bylaws of the Company, the Board appointed Paul Kim to serve as a Class II director, with an initial term expiring at the Company’s 2024 annual meeting of stockholders, filling the vacancy on the Board.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
Start not stated–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Exagen Inc.
Other people whose current roles at this company are on record from its filings.
- John Aballi CEO, CFO, Board Member
- Tina S. Nova Chairman
- Jeffrey Black CFO
- Mark Hazeltine COO
- Bruce C. Robertson Board Member
- Charles S. McKhann Board Member
- Frank Stokes Board Member
- Scott D. Kahn Board Member
- Scott D. Kahn, Ph.D. Board Member
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.